Literature DB >> 4168763

The pharmacology of heparin and heparinoids.

L B Jaques.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4168763     DOI： 10.1016/s0079-6468(08)70443-0

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN： 0079-6468


× No keyword cloud information.
  6 in total

1.  Exogenous 35S-labeled heparin: organ distribution and metabolism.

Authors:  T Stau; J Metz; R Taugner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

2.  The treatment of pulmonary embolism.

Authors:  R L Hackney
Journal:  J Natl Med Assoc       Date:  1971-09       Impact factor: 1.798

3.  An inverse relationship between heparin content and antibody response in genetically selected mice. Sex effect and evidence of a polygenic control for skin heparin concentration.

Authors:  A H Straus; O A Sant'anna; H B Nader; C P Dietrich
Journal:  Biochem J       Date:  1984-06-15       Impact factor: 3.857

4.  Low-density-lipoprotein binding by mast-cell granules. Demonstration of binding of apolipoprotein B to heparin proteoglycan of exocytosed granules.

Authors:  J O Kokkonen; P T Kovanen
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

Review 5.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 6.  Protamine--antagonist to heparin.

Authors:  L B Jaques
Journal:  Can Med Assoc J       Date:  1973-05-19       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.